chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Headache, Nausea
Clinical narrative: it started on Sat nite very hot on Sunday; headache; nausea; This is a spontaneous report from a contactable consumer (patient).  A 76-year-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via unknown route of administration at left arm on 12Feb2021 at 12:30 pm (lot number: EN6201, age at vaccination 76-year-old) as single dose for COVID-19 immunisation at Public Health Clinic. The patient medical history and concomitant medications were not reported. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) via unknown route of administration at left arm on 22Jan2021 (lot number: EL8982) as single dose for COVID-19 immunisation, had headache and nausea. The patient did not receive any other medications the patient received within 2 weeks of vaccination. After the shot, the patient felt fine all weekend and on Sat night the patient had very hot, on Sunday the patient had headache, nausea on 20Feb2021 at 18:00. The patient had not received any treatment for the events. The outcome of the event nausea was unknown. The outcome of other events was not recovered.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site soreness; This is a spontaneous report from a Pfizer-sponsored program. A contactable Female consumer reported for herself that:  A female patient of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced injection site soreness / fortunate enough to not get side effects aside from the injection site soreness on an unspecified date. Reporter stated that, she took pain medication before the first dose and she was asking if she could take another pain medication after the first dose that has nothing to do with the covid vaccine. Outcome of event was unknown.   No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Bile acid malabsorption, Diarrhoea, Hyperhidrosis, Illness, Vomiting
Clinical narrative: At 9 pm the night of my second shot I become violently ill.; I vomited all night; eventually just throwing up bile; I also had diarrhea; I had cold sweats and was up every hour; This is a spontaneous report from a contactable consumer (patient).  A 37-year-old non-pregnant female patient second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot number: EN6201), dose 2 via an unspecified route of administration, administered in left arm on 21Feb2021 at 12:15 immunization (at the age of 37-year-old) as DOSE 2, SINGLE for COVID-19. The patient medical history was not reported. No known allergies. Concomitant medications included venlafaxine hydrochloride (EFFEXOR), lisdexamfetamine mesilate (VYVANSE) and trazodone. The previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot number: EN5318), dose 1 via an unspecified route of administration, administered in right arm on 31Jan2021 (at the age of 37-year-old) at 13:30 as dose 1, single for COVID-19 immunization. The patient did not have COVID prior vaccination and not tested for COVID post vaccination. No other vaccine in four weeks. On 21Feb2021 at 21:00, the night of her second shot she become violently ill, vomited all night, eventually just throwing up bile, also had diarrhea and had cold sweats and was up every hour. The patient did not receive any treatment for adverse events except vomited all night. The patient was treated with Zofran at 8 am for vomited all night. On an unspecified date, the patient recovered from vomiting and outcome of all other events was recovering.  Follow-up attempts completed. No further information expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Migraine, Nausea
Clinical narrative: Headache similar to migraines; headache similar to migraines; nausea; tired; This is a spontaneous report from a contactable consumer. This 44-years-old male consumer(patient) reported that: A 44-year-old male patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: EN6203), via an unspecified route administered in right arm on 15Feb2021 16:00 (age at vaccination 44-year-old) as DOSE 1, SINGLE for COVID-19 immunization. The patient medical history was reported as none. The patient had no known allergies. Concomitant medication included hydrocodone bitartrate, paracetamol (NORCO) within two weeks of vaccines from an unspecified date. The patient did not receive any other vaccines within four weeks prior vaccination. The patient not had COVID prior vaccination and not tested for COVID post vaccination. On 16Feb2021 05:30, the patient experienced headache similar to migraines, nausea and tired. The patient did not receive any treatment for the events. The outcome of the events was recovered on an unspecified date in 2021.  Follow-up attempts are completed. No further information was expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Lymphadenopathy on the neck; This is a spontaneous report from a contactable nurse. This 60-year-old male nurse reported. A 60-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/lot number: unknown) via unknown route in left arm on 19Feb2021 at 08:15 as DOSE 1, SINGLE (at the age of 60 years old) for COVID-19 immunisation. The patient medical history included bipolar disorder and past drug event with Aspirin allergy. Concomitant medication included valproate semisodium (DIVALPROEX) 250 mg for an unknown indication from an unknown date. The patient did not receive other vaccine in four weeks. On 21Feb2021 at 11:00 AM, the patient experienced Lymphadenopathy on the neck. The patient did not receive the treatment. Patient did not have COVID prior vaccination and tested for COVID post vaccination. On 25Jan2021 the lab data included Nasal Swab and PCR with negative results. The outcome of the event was recovered.  Follow-up attempts completed. No further information expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: Soreness and tenderness at the injection site; General but mild full body aches; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non pregnant female patient received bnt162b2 (FIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in left arm on 23Feb2021 09:45 (at age of 49-year-old) as dose 1, single for covid-19 immunization at clinic. Medical history included breast cancer survivor. Concomitant medications (received within 2 weeks of vaccination) included cyanocobalamin (B12 [CYANOCOBALAMIN], 1000 mg), colecalciferol (D3, 2000 IU). No allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID. Since the vaccination, the patient was not tested for COVID-19. On 23Feb2021 16:00, the patient experienced soreness and tenderness at the injection site, general but mild full body aches. The outcome of events was recovering.  Follow-up attempts completed. No further information expected.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Lacrimation increased, Myalgia
Clinical narrative: slight muscle ache; headache; chills; severe body aches (all); sore throat; tired; watery eyes; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EN6200) via an unspecified route of administration, administered in Arm Left on 22Feb2021 07:30 (at the age of 54-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included Kidney donor. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration, on 01Feb2021 as DOSE 1, SINGLE for covid-19 immunisation. On 22Feb2021, the patient experienced slight muscle ache, headache, chills within 2 hours. 12 hours post vaccine, severe body aches (all), chills, sore throat, tired and watery eyes. These lasted 24 hours. Some relief after 24 hours, some lingering effects 36 hours after. The patient did not receive any treatment for the events. The outcome of the events was recovering.  Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021201478 same patient, different drug/AE
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain
Clinical narrative: slight muscle ache; headache; chills; severe body aches (all); sore throat; tired; watery eyes; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EN6200) via an unspecified route of administration, administered in Arm Left on 22Feb2021 07:30 (at the age of 54-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included Kidney donor. The patient's concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration, on 01Feb2021 as DOSE 1, SINGLE for covid-19 immunisation. On 22Feb2021, the patient experienced slight muscle ache, headache, chills within 2 hours. 12 hours post vaccine, severe body aches (all), chills, sore throat, tired and watery eyes. These lasted 24 hours. Some relief after 24 hours, some lingering effects 36 hours after. The patient did not receive any treatment for the events. The outcome of the events was recovering.  Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021201478 same patient, different drug/AE
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 35-year-old (non pregnant) female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, solution for injection, batch/lot# not reported), at the vaccination age of 35, via an unspecified route of route of administration, in left arm, on Feb 23, 2021, at 18:30, single dose, for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history not reported. Concomitant medications included Xanax (alprazolam) for an unspecified indication (start and stop date not reported). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient has no known allergies. Prior to vaccination, patient was not diagnosed with COVID-19. On Feb 23, 2021, at 19:00, patient felt lightheaded and dizzy. On Feb 23, 2021 (post vaccination), patient had a COVID-19 nasal swab test (results pending). The patient did not receive any treatment for the events. The outcome of the events: recovering. Information about batch/lot number cannot be obtained. Follow-up attempts completed. No further information expected.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: headache; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A male patient of an unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: Not reported, Expiry Date: Not reported), via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced headache. It was reported by the patient that he received second dose of covid vaccine yesterday. During the night he woke up with a headache and took some Advil for the treatment of the headache. He was wondering if that will decrease the efficacy of the vaccine. Outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Myalgia
Clinical narrative: Swollen axillary lymph node in L arm where I received my vaccine dose; headache; fatigue; Moderate Myalgia; This is a spontaneous report from a contactable consumer (patient). A 33-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration, administered in left arm on 23Feb2021 10:15 (at the age of 33-years-old) as dose 2, single for covid-19 immunization at workplace clinic. The patient medical history and concomitant medications were not reported. The patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number was not reported, expiration date was not reported), via an unspecified route of administration, administered in left arm on 04Feb2021 11:30 as dose 1, single for covid-19 immunization. The patient previously took amoxicillin and experienced known allergies to amoxicillin. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccine with in four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. It was reported that on 24Feb2021 02:30am the patient experienced moderate myalgia, headache, fatigue and on 25Feb2021 08:00am the patient experienced swollen axillary lymph node in L arm where she received her vaccine dose. No treatment was received for the adverse events. The outcome of the events moderate myalgia, headache, fatigue was recovering and outcome of the event swollen axillary lymph node in L arm where she received her vaccine dose was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Dry mouth
Clinical narrative: Dry mouth that last for 3 hrs.; This is a spontaneous report from a contactable consumer or other non-HCP (patient himself). A 37-year-old male patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- EN6198) via an unspecified route of administration, administered in left arm on 22Feb2021 14:30 (at the age of 37-years-old) as dose 1, single for COVID-19 immunization. Medical history was reported as none. The patient known allergies was reported as none. Vaccination facility type was reported as Health Department. The concomitant medications included emtricitabine, tenofovir alafenamide fumarate (DESCOVY) taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine within 4 weeks prior to the covid vaccination. Since the vaccination, the patient had not been tested for COVID-19. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 22Feb2021 at 15:00, the patient experienced dry mouth that last for 3 hrs. The patient did not receive any treatment for the dry mouth. The outcome of the event was recovered on 22Feb2021.  Follow-up (11May2021): Follow-up attempts completed. No further information expected.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Vaccination site erythema, Vomiting
Clinical narrative: Chills; had a little throwing up of clear phlegm this morning; Fatigue/ feels tired; redness at injection site; This is a spontaneous report from a Pfizer sponsored program reported from a contactable consumer (patient). An 80-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was not reported) via an unspecified route of administration, administered in left arm on 19Feb2021 (at the age of 80-year-old) as dose 1, single for COVID-19 immunisation. Medical history included ongoing non-drinking cirrhosis of liver from Apr2020, Crohn's disease, anaemia and blood pressure from an unknown date and unknown if ongoing. Concomitant medications included ongoing Entyvio taken for Crohn's disease from 28Jan2021, ongoing iron taken for anaemia from an unspecified start date, ongoing Metoprolol taken for blood pressure from an unspecified start date and ongoing Amlodipine taken for blood pressure from 07Dec2020. No vaccine was administered on same date of Pfizer suspect. On 19Feb2021, patient had redness at the injection site, he experienced fatigue/ feels tired on 22Feb2021 and on 23Feb2021 patient experienced chills and had a little throwing up of clear phlegm. He did drink a lot of water. Maybe he had not drank enough. He walks 2-2.5 miles a day. He thinks little throwing up of clear phlegm was related to Crohn's Disease. His last dose of Entyvio was on 11Feb2021. His doctor said that was ok to take. No prior vaccination within 4 weeks. Outcome of the event redness at injection site recovered on 19Feb2021, Chills recovered on 23Feb2021, fatigue/ feels tired was not recovered and had a little throwing up of clear phlegm was unknown at the time of reporting.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: Headache; some nausea; body soreness; This is a spontaneous report from a contactable consumer or other non hcp (Patient herself). A 51-year-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 23Feb2021 07:30 (Batch/Lot Number: EL9265) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Other medication in two weeks was provitalize. No treatment received by AE. No COVID prior vaccination and not tested post vaccination. No Known Allergies.The patient experienced headache, some nausea, body soreness on 23Feb2021 21:30. The with outcome of the events was recovering.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Pain, Vomiting
Clinical narrative: diarrhea; Body aches; nausea; vomiting; This is a spontaneous report from a contactable consumer (patient). A 22-year-old non pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL9267, Expiry date: not reported), via an unspecified route of administration in left arm on 22Feb2021 16:15 (at age of 22-year-old) as dose 2, single for covid-19 immunization in hospital. Patient was not pregnant at the time of vaccination. The patient medical history was reported as none. The patient's concomitant medications were not reported. Patient had no known allergies. The patient had not received any other vaccine within 4 weeks. The patient had not received any other medications within 2 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19 and post the vaccination, the patient was not tested for COVID-19. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: EL9261, Expiration Date: Not reported), via an unspecified route of administration in left arm on 01Feb2021 11:00 (at age of 22-year-old) as dose 1, single for covid-19 immunization. On 23Feb2021 at 05:00, the patient experienced diarrhea, body aches, nausea and vomiting. No therapeutic measures were taken in response to the events. Adverse event resulted in clinic visit. The outcome of the events was recovering.   Follow-up attempts completed. No further information expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Vaccination site pain
Clinical narrative: Mild injection site soreness; Mild headache; Tired; This is a spontaneous report from a contactable consumer (patient). A 59-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247, Expiration date not reported), via an unspecified route of administration, administered in left arm on 22Feb2021 13:15 (at the age of 59 years) as dose 1, single for COVID-19 immunization. Medical history included acid reflux, Hot flashes, and codeine sensitive from an unknown date and unknown if ongoing. Patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. List of any other medications the patient received within 2 weeks of vaccination: yes. Patient was on unspecified concomitant medication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Feb2021 06:00, the patient experienced mild injection site soreness, mild headache, and tired. Patient did not receive any treatment for the adverse events. Patient assessed the case as non-serious. The outcome of the events was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pruritus, Pain in extremity
Clinical narrative: arm soreness; itchy around injection site; fatigue; This is a spontaneous report from a contactable consumer. A 77-year-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot Number: Not reported), via an unspecified route of administration on 22Feb2021 (at the age of 77 years-old)  as Single dose for covid-19 immunisation.  Medical history included thyroid disease, high cholesterol from an unknown date and unknown if ongoing. Concomitant medication(s) included levothyroxine, rosuvastatin taken for an unspecified indication, start and stop date were not reported. On 22Feb2021, The patient experienced fatigue and arm soreness, itchy around injection site on 23Feb2021. The date of when she was aware of these symptoms was 22Feb2021 (fatigue) and 23Feb2021 (arm soreness, itchy around injection site). The patient was her mom and she had the second shot on 22Feb2021. The outcome of fatigue, arm soreness, itchy around injection site was recovering.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Mild/moderate pain at the site of injection; This is a spontaneous report from a contactable consumer (patient himself). A 36-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: not reported, expiration date: not reported), via an unspecified route of administration, administered in Arm Left on 23Feb2021 10:00 as dose 1, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Feb2021, the patient experienced mild/moderate pain at the site of injection. Patient did not received any treatment. Clinical outcome of the events was reported as recovering.  No follow-up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Pain, Vaccination site swelling
Clinical narrative: Moderate pain and soreness at injection site and entire shoulder and neck area for 3 days.; soreness at injection site and entire shoulder and neck area for 3 days.; soreness at injection site and entire shoulder and neck area for 3 days.; soreness at injection site and entire shoulder and neck area for 3 days.; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-year-old non pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: ER9581), via an unspecified route of administration in the right arm on 22Feb2021 at 04:15 PM (at the age of 67-years-old) as dose 1, single for COVID-19 immunisation at other facility. Medical history includes diabetes, coronary artery disease and previous breast cancer; all were from an unknown date and unknown if ongoing. The patient was allergic to latex and codeine products. Concomitant medications included carvedilol; rosuvastatin; metformin and clopidogrel; all were taken for an unspecified indication, start and stop date were not reported and received within 2 weeks of vaccination. The patient previously took codeine and experienced drug hypersensitivity. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Feb2021 at 04:45 PM, the patient experienced moderate pain and soreness at injection site and entire shoulder and neck area for 3 days. No therapeutic measures were taken as a result of reported events. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Outcome of the events was recovering.  Follow-up attempts completed. No further information expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm soreness at injection site; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 44-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247, Expiration date: not reported) via an unspecified route of administration, administered in arm left on 22Feb2021 at 15:45 (at the age of 44-year-old) as dose 1, single for COVID-19 immunization at workplace clinic. Medical history was not reported. Patient was not pregnant at the time of vaccination. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Patient did not receive other medications within 2 weeks of vaccination. On 23Feb2021, patient experienced arm soreness at injection site. Patient did not receive any treatment for the adverse event. The outcome of the event was reported as resolving.  No follow-up attempts are needed. No further information is expected.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pain
Clinical narrative: hardly hurt but felt the pinch with both shots; hardly hurt; This is a spontaneous report from a contactable consumer (patient). A 84-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left (left shoulder) on 19Feb2021 (at the age of 84-year-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left (left shoulder) on 28Jan2021 (at the age of 84-year-old) as DOSE 1, SINGLE for covid-19 immunisation and experienced same events it hardly hurt, but she felt the pinch with both shots. On an unspecified date, the patient experienced hardly hurt but felt the pinch with both shots. Patient questioning if the vaccine is working because she had no reaction not even a sore arm initially. Reported that 2nd shot was taken 2 weeks after her first one. it hardly hurt, but she felt the pinch with both shots. The outcomes of events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Lymphadenopathy, Oropharyngeal pain
Clinical narrative: Swollen lymph node; experiencing throat pain; This is a spontaneous report from a contactable consumer (patient) via medical information team. A 58-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, #lot: EL9262) via an unspecified route of administration, administered in arm left on 20Jan2021 (at the age of 58-years-old) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included hodgkin's disease from 1985 to an unknown date. The patient's concomitant medications were not reported. On an unspecified date, it was reported that the patient experienced swollen lymph node and that she was experiencing throat pain. She was done with both doses of the vaccine. The patient wants to know if this has been reported as a side effect of the covid vaccine. The patient was taking COVID Vaccine as she was extremely vulnerable. She was missing part of a lung and had Hodgkin's lymphoma. She has been having pain in her throat. It was not like a sore throat. It was like there was a painful obstruction. She thinks it might be a swollen lymph node. The patient inquired if there been reports of swollen lymph nodes after receiving the COVID vaccines and if any others reporting this. It was reported that the patient received the second dose on 16Feb2021. The patient had blood work a week ago on an unspecified date in Feb2021. The doctor has the results. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Insomnia, Migraine, Pain, Vomiting
Clinical narrative: unable to sleep at night; She felt like she wanted to die; migraines; very achy; throwing up,; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9267), via an unspecified route on 15Feb2021 at 11:30 (at the age of 65-years) as dose 1, single in the left arm for covid-19 immunisation. The patient medical history included irritable bowel syndrome. The patient concomitant medications were not reported. The patient previously received pneumonia vaccine on 04Jan2021. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced migraines, very achy, throwing up unable to sleep at night on 17Feb2021. Patient stated 10 days later I'm still having migraines, I feel like dying. She started having daily migraines. She has had a problem with migraines off and on for 4 years. She was also very achy. She wishes she could throw up. She doesn't sleep at night. She is concerned that this will happen with the second dose. The pain with the migraine is so bad. The migraines started at noon. She felt like she wanted to die. They start every afternoon. The feeling of wanting to throw up comes and goes. It is not constant. It comes in cycles. Last night she took two Ibuprofen because she could not take it anymore. The outcome of the events migraines was not recovered, very achy was recovering and other events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Migraine, Pain
Clinical narrative: Arm pain at site of injection; Migraine headache; pain requiring Advil 3 tablets; This is a spontaneous report from a contactable other hcp (Patient). A 40-years-old non-pregnant female patient received a dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection, Lot Number: UNKNOWN), via intramuscular, administered in Arm Left on 23Feb2021 11:30 (at the age of 40-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. Allergies to medications, food, or other products was reported as no. Patient not received any other vaccine prior to two weeks of vaccination. List of any other medications the patient received within 2 weeks of vaccination was reported as no.It was reported that patient was not a pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Feb2021 00:30 the patient experienced Arm pain at site of injection, Migraine headache starting 12 hours after the vaccine and lasting 7 hours and 8/10 pain requiring Advil 3 tablets. The patient received treatment for the events. Outcome of the events was recovered on an unspecified date in 2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: tired; arm soreness; This is a spontaneous report from a contactable consumer or other non health care professional. A 55-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: not provided) via an unspecified route of administration on 23Feb2021 as DOSE 1, SINGLE for COVID-19 immunization. Medical history and concomitant medications were not reported. known allergies were unknown. The patient experienced arm soreness and tired on 24Feb2021. It was unknown whether therapeutic measures were taken as a result of reported events. It was unknown, whether the patient was diagnosed with COVID-19, prior to vaccination and since the vaccination. Outcome of the events was unknown.  Information on lot and batch number has been requested. Follow-up attempts completed. No further information expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Fatigue, Pain
Clinical narrative: Fatigue; depression; body aches; This is a spontaneous report from a contactable consumer or other non hcp. A 68-year-old non-pregnant female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EL9265), dose 2 via an unspecified route of administration, administered in Arm Right on 13Feb2021 09:30 AM (Batch/Lot Number: EL9265) as DOSE 2, SINGLE for covid-19 immunisation (at the age of 68-year-old). The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received first dose of bnt162b2 on 23Jan2021 08:30 AM in Left arm for covid-19 immunisation. On 21Feb2021 patient experienced Fatigue, depression, and body aches. The patient did not received treatment. The outcome of the event was recovered.  No follow-up attempts are needed. No further information is expected.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Paraesthesia
Clinical narrative: feeling a little tingling; bad headache from eyebrows into her teeth, both upper and lower teeth are aching, and into the back of her neck; could not stand the pain; This is a spontaneous report from a contactable consumer (patient). A 83-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6201; Expiration Date: Jun2021) via an unspecified route of administration, administered in right arm on 23Feb2021 13:30 (at the age of 83-year-old) as dose 1, single for COVID-19 immunisation. Medical history included arthritis from an unknown date and unknown if ongoing, normally has headaches, like sinus headaches, sinus conditions and pain from an unknown date and unknown if ongoing. Concomitant medication included Tylenol taken for arthritis and pain. On 23Feb2021, the patient experienced bad headache from eyebrows into her teeth, both upper and lower teeth are aching, and into the back of her neck. Patient normally takes Tylenol for Arthritis and the person who gave the patient the COVID vaccine, told her to try not to take the Tylenol, but patient could not stand the pain, so at 18:30 or 19:00 last night (on 23Feb2021), the patient took some Tylenol. Patient was wondering if she was doing okay by taking the Tylenol to help alleviate the pain. She has headaches, like sinus headaches, daily. She takes a couple Tylenol and on a CPAP machine to help with her headaches, but her typical headache was not to the degree that she had yesterday. she did get a notice for her next appointment for the second dose, for 16MAR2021.Patient stated that the headache reoccurred at 6:00 this morning (on 24Feb2021) and she took Tylenol and now she was feeling a little tingling. Patient had no other vaccines on the same day as her COVID vaccine. Outcome of the event bad headache from eyebrows into her teeth, both upper and lower teeth are aching, and into the back of her neck was recovering, outcome of pain and feeling a little tingling was unknown at the time of reporting  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: had soreness on his arm after 1st dose; This is a spontaneous report from a Pfizer-sponsored program. A contactable male consumer (Patient) reported that: A male of unspecified age received first dose of bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number not reported) via an unspecified route of administration, administered on 29Jan2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications not reported. On 29Jan2021 patient experienced soreness on his arm. The patient received took 2 Advil and 1 Tylenol an hour before his 2nd dose. The outcome of event was unknown.  Follow-up attempts completed. No further information expected. Information about lot/batch number cannot be obtained
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: warm arm after receiving 2nd dose of Covid vaccine; This is a spontaneous report from a contactable consumer or other non hcp via pfizer-sponsored program. A female patient of an unspecified age received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: Not reported) via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: Not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient experienced warm arm after receiving 2nd dose of covid vaccine on an unspecified date. Caller stated that there was some kind of chemical in the delivery of vaccines that causes her daughter anaphylactic shock. She said the same chemical was in the Covid vaccine. She was wondering if Pfizer was working on a pill or something for people who could not take the regular vaccines as her daughter would like to be immune to Covid too. Caller then stated that she got a warm arm after receiving 2nd dose of Covid vaccine. Consumer calling on behalf of her daughter who recently finished up chemotherapy treatment for breast cancer, was now on radiation, and wanted to receive the Pfizer-Biontech Covid19 vaccine. The oncologist believed that her daughter had an allergic reaction to the 'vehicle' that the chemo was being delivered in, not the chemotherapy drug itself, which caused her daughters face and throat to swell up. The caller stated the fluid used to deliver the medication might have been called "technol". Did Pfizer had plans to develop a different delivery system so that her daughter could get the vaccine. Caller stated she was "So grateful for what Pfizer had done for them. Her husband and mother and she received their 2nd dose last week with no reaction. Their friends who got the other shot could not say the same. They were so grateful. Seriousness of the event was non serious. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chills, Headache, Malaise, Nausea
Clinical narrative: some of it looked a little blurry/Blurry vision; bad headaches; Chills; Nausea; she didn't feel good practically the whole night; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 74-year-old female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9269; Expiration Date: 31May2021) via an unspecified route of administration on 17Feb2021 (at the age of 74-years-old) as dose 2, single for COVID-19 immunization. The medical history of the patient included diabetes, high blood pressure, gastro oesophageal reflux disease (GERD). The concomitant medications of the patient included omeprazole taken for gastro oesophageal reflux disease, metoprolol tartrate, pravastatin sodium, losartan potassium, liraglutide (VICTOZA), metformin, anastrozole, calcium carbonate, colecalciferol (CALCIUM 600+D3), denosumab (PROLIA had the shot in January for the bones) and multivitamin. The patient previously received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9262; Expiration Date: May2021) via an unspecified route of administration on 27Jan2021 (at the age of 74-years-old) as single dose for COVID-19 immunization. The caller stated she received the first dose of the vaccine on 27Jan2021 and the second dose on 17Feb2021, a week ago that day. Previous night on 23Feb2021, she started having symptoms like she was doing math with her granddaughter and some of it looked a little blurry, then she had a headache, chills, felt nauseous, and she didn't feel good practically the whole night. She felt a little better. She stated she still had a headache but the other part was feeling a little better. She asked if it was normal for those symptoms to occur 6 days after the vaccine. She didn't get any problem a couple of days after the shot. She thought she was doing good. That day the headache wasn't as bad. It was dully, aching pain. The chills had only been a little that morning and as the day went seemed to be better. She was asking was that a side effect from the COVID shot. Could she get side effects that far after getting the shot. Caller stated reading the medication list given her a headache. When she went to the doctor they ask her for the medications and she wouldn't remember. That was probably why she had the headache. The events was reported as non serious. The patient underwent lab tests and procedures which included blood work: unknown results on an unspecified date in 2021. The patient recovered from the events some of it looked a little blurry/Blurry vision, chills, nausea, she didn't feel good practically the whole night on an unspecified date in 2021 and the outcome of the event bad headaches was reported as not resolved.  No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred
Clinical narrative: some of it looked a little blurry/Blurry vision; bad headaches; Chills; Nausea; she didn't feel good practically the whole night; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 74-year-old female patient received second dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9269; Expiration Date: 31May2021) via an unspecified route of administration on 17Feb2021 (at the age of 74-years-old) as dose 2, single for COVID-19 immunization. The medical history of the patient included diabetes, high blood pressure, gastro oesophageal reflux disease (GERD). The concomitant medications of the patient included omeprazole taken for gastro oesophageal reflux disease, metoprolol tartrate, pravastatin sodium, losartan potassium, liraglutide (VICTOZA), metformin, anastrozole, calcium carbonate, colecalciferol (CALCIUM 600+D3), denosumab (PROLIA had the shot in January for the bones) and multivitamin. The patient previously received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9262; Expiration Date: May2021) via an unspecified route of administration on 27Jan2021 (at the age of 74-years-old) as single dose for COVID-19 immunization. The caller stated she received the first dose of the vaccine on 27Jan2021 and the second dose on 17Feb2021, a week ago that day. Previous night on 23Feb2021, she started having symptoms like she was doing math with her granddaughter and some of it looked a little blurry, then she had a headache, chills, felt nauseous, and she didn't feel good practically the whole night. She felt a little better. She stated she still had a headache but the other part was feeling a little better. She asked if it was normal for those symptoms to occur 6 days after the vaccine. She didn't get any problem a couple of days after the shot. She thought she was doing good. That day the headache wasn't as bad. It was dully, aching pain. The chills had only been a little that morning and as the day went seemed to be better. She was asking was that a side effect from the COVID shot. Could she get side effects that far after getting the shot. Caller stated reading the medication list given her a headache. When she went to the doctor they ask her for the medications and she wouldn't remember. That was probably why she had the headache. The events was reported as non serious. The patient underwent lab tests and procedures which included blood work: unknown results on an unspecified date in 2021. The patient recovered from the events some of it looked a little blurry/Blurry vision, chills, nausea, she didn't feel good practically the whole night on an unspecified date in 2021 and the outcome of the event bad headaches was reported as not resolved.  No follow-up attempts are possible. No further information is expected.